Transaction Details

Footnotes

The options vest and become exercisable as to 34% of the underlying shares on January 1, 2018, 33% of the underlying shares on January 1, 2019 and 33% of the underlying shares on January 1, 2020. | The options vest and become exercisable as to 34% of the underlying shares on January 1, 2019, 33% of the underlying shares on January 1, 2020 and 33% of the underlying shares on January 1, 2021. | Granted pursuant to the issuer's 2015 Equity Incentive Plan. | The options vest and become exercisable as to 34% of the underlying shares on January 1, 2020, 33% of the underlying shares on January 1, 2021 and 33% of the underlying shares on January 1, 2022. | The options vest and become exercisable as to 34% of the underlying shares on January 1, 2021, 33% of the underlying shares on January 1, 2022 and 33% of the underlying shares on January 1, 2023. | The options vest and become exercisable as to 34% of the underlying shares on January 1, 2022, 33% of the underlying shares on January 1, 2023 and 33% of the underlying shares on January 1, 2024. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.43 to $101.33. | The total reported in Column 5 includes 3,352 restricted stock units and 311,834 shares of common stock. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.05 to $101.27. | The total reported in Column 5 includes 3,352 restricted stock units and 290,765 shares of common stock. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.25 to $100.05. | The total reported in Column 5 includes 3,352 restricted stock units and 280,364 shares of common stock.